| dc.contributor.author | Mattaini, Katherine Ruth | |
| dc.contributor.author | Sullivan, Mark Robert | |
| dc.contributor.author | Vander Heiden, Matthew G. | |
| dc.date.accessioned | 2017-02-23T19:46:57Z | |
| dc.date.available | 2017-02-23T19:46:57Z | |
| dc.date.issued | 2016-07 | |
| dc.identifier.issn | 0021-9525 | |
| dc.identifier.issn | 1540-8140 | |
| dc.identifier.uri | http://hdl.handle.net/1721.1/107134 | |
| dc.description.abstract | Serine metabolism is frequently dysregulated in cancers; however, the benefit that this confers to tumors remains controversial. In many cases, extracellular serine alone is sufficient to support cancer cell proliferation, whereas some cancer cells increase serine synthesis from glucose and require de novo serine synthesis even in the presence of abundant extracellular serine. Recent studies cast new light on the role of serine metabolism in cancer, suggesting that active serine synthesis might be required to facilitate amino acid transport, nucleotide synthesis, folate metabolism, and redox homeostasis in a manner that impacts cancer. | en_US |
| dc.description.sponsorship | American Association for Cancer Research | en_US |
| dc.description.sponsorship | Burroughs Wellcome Fund | en_US |
| dc.description.sponsorship | David H. Koch Institute for Integrative Cancer Research at MIT | en_US |
| dc.description.sponsorship | Ludwig Center for Molecular Oncology at MIT | en_US |
| dc.description.sponsorship | Stand Up To Cancer | en_US |
| dc.description.sponsorship | National Science Foundation (U.S.) (NSF Graduate Research Fellowship Program) | en_US |
| dc.description.sponsorship | National Institutes of Health (U.S.) (NIH grant R21 CA198028) | en_US |
| dc.language.iso | en_US | |
| dc.publisher | Rockefeller University Press | en_US |
| dc.relation.isversionof | http://dx.doi.org/10.1083/jcb.201604085 | en_US |
| dc.rights | Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license | en_US |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | en_US |
| dc.source | Rockefeller University Press | en_US |
| dc.title | The importance of serine metabolism in cancer | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Mattaini, Katherine R., Mark R. Sullivan, and Matthew G. Vander Heiden. “The Importance of Serine Metabolism in Cancer.” The Journal of Cell Biology 214, no. 3 (July 25, 2016): 249–257. | en_US |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | en_US |
| dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
| dc.contributor.mitauthor | Mattaini, Katherine Ruth | |
| dc.contributor.mitauthor | Sullivan, Mark Robert | |
| dc.contributor.mitauthor | Vander Heiden, Matthew G. | |
| dc.relation.journal | Journal of Cell Biology | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dspace.orderedauthors | Mattaini, Katherine R.; Sullivan, Mark R.; Vander Heiden, Matthew G. | en_US |
| dspace.embargo.terms | N | en_US |
| dc.identifier.orcid | https://orcid.org/0000-0003-0046-1360 | |
| dc.identifier.orcid | https://orcid.org/0000-0001-5765-0459 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-6702-4192 | |
| mit.license | PUBLISHER_CC | en_US |